Karriereverlauf von David Green
Ehemalige bekannte Positionen von David Green
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| AMGEN INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.09.1997 | 01.02.2008 |
| ABBOTT LABORATORIES | Corporate Officer/Principal | - | - |
| UNITED THERAPEUTICS CORPORATION | Direktor/Vorstandsmitglied | - | - |
| ReSearch Pharmaceutical Services, Inc. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Aquinox Pharmaceuticals, Inc.
 Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Statistik
International
| Vereinigte Staaten | 5 |
| Kanada | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 3 |
| Director/Board Member | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 5 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| UNITED THERAPEUTICS CORPORATION | Health Technology |
| AMGEN INC. | Health Technology |
| ABBOTT LABORATORIES | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Aquinox Pharmaceuticals, Inc.
Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | Health Technology |
| ReSearch Pharmaceutical Services, Inc. |
- Börse
- Insiders
- David Green
- Erfahrung
